Cardiologia Croatica, Vol. 7 No. 11-12, 2012.
Professional paper
Meet the requirements of the new European recommendations for the treatment of dyslipidemias by using potent statins.
Sanja Brus
; Krka, d. d., Novo mesto, Slovenia
Breda Barbič-Žagar
orcid.org/0000-0002-1173-7361
; Krka, d. d., Novo mesto, Slovenia
Abstract
Recently issued European guidelines introduced new classification of patients into 4 risk categories and mandated even lower target lipid levels for patients at very high risk. In the light of the fact that about half of patients in Europe receiving lipid-lowering therapy were not reaching target lipid levels as set in the 2007 European Society of Cardiology guidelines, new target lipid levels may be seen as an even greater challenge. However by using potent statins such as rosuvastatin or atorvastatin and in appropriate doses, the requirements of the new European recommendations can be met.
Keywords
guidelines; LDL cholesterol; regression of atherosclerosis; rosuvastatin
Hrčak ID:
94697
URI
Publication date:
4.12.2012.
Visits: 1.378 *